[ Skip to main article on this page ]

Other languages: [ fr | de | es | it | pt | nl | ja | ko | zh | ar | cy ]

Welcome to Insulin Pumpers UK [Home] [This section: Experiences] [Advice] [UK issues] [Discussion groups] [Products] [Links] [About us]

[ What is an insulin pump? | Pros and cons of pumping | Just like wearing a yoyo | Not controlled, but in control! | Rewriting the diabetes rulebook | Insulin pump evaluation | Wearing the pump | Wearing a continuous glucose sensor | To pump or not to pump? | Pumps in pregnancy | Life on a pump | My perfect pump | Using the insulin pump during pregnancy | My pump | My CGMS test | A look back over year one | Diabetes UK Family Weekend | I want the best for my son | Active News - April 2002 | Finally got plugged in | Eleven months and counting | Back to injections | Using a DiaPort | An insulin pump for Sasha ]

advanced search


This page as a pdf file

Pros and cons of pumping

Discussion of the many advantages and disadvantages of insulin pump therapy

Using a pump is not all easy going. Diana Maynard examines some of the pros and cons of insulin pump therapy:

Advantages

Disadvantages


References

  1. I. Lager et al. Reversal of insulin resistance in Type 1 diabetes after treatment with continuous subcutaneous insulin infusion. BMJ 287: 1661-1663, 1983.
  2. H. Beck-Nielsen et al. Improved in vivo insulin effect during continuous subcutaneous insulin infusion in patients with IDDM. Diabetes 33: 832-837, 1984.
  3. C. Binder et al. Insulin pharmacokinetics. Diabetes Care 7:188-199, 1984.
  4. T. Lauritzen et al. Pharmacokinetics of continuous subcutaneous insulin infusion. Diabetologia 24: 326-329, 1983.
  5. E.A. Boland, M. Grey, A. Oesterle, L. Fredrickson, W.V. Tamborlane Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with Type 1 diabetes. Diabetes Care 22(11): 1779-84, 1999.
  6. K. Dahl-Jorgensen et al. Effect of near normoglycemia for two years on progression of early diabetic retinopathy, nephropathy and neuropathy: the Oslo study. BMJ 293: 1195-1201, 1986.
  7. J.J. Bending et al. Complications of insulin infusion pump therapy. JAMA 253: 2644, 1985.

Author: Diana Maynard <d.maynard@dcs.shef.ac.uk>. Diana Maynard is not a medical professional. She has Type 1 diabetes and uses an insulin pump. The information given here is based on her own personal experience and the listed references. More about Diana Maynard...

Created: March 2000; Last updated: Tuesday 5 June 2001


Other pages about pumps

[ Funding issues | Pros and cons of pumping | Diabetes UK on pump therapy | Pumps in the Republic of Ireland | What is an insulin pump? | Just like wearing a yoyo | Not controlled, but in control! | Rewriting the diabetes rulebook | To pump or not to pump? | Pumps in pregnancy | Using the insulin pump during pregnancy | Life on a pump | UK pump news | Which pump? | MiniMed | Disetronic | Animas | Books to help with diabetes | Other pump websites | My pump ]


Other pages about infusion sets

[ What is an insulin pump? | Pros and cons of pumping | Wearing a pump | Bad infusion sites and high bgs | Infusion sets | Books to help with diabetes | Using a DiaPort ]


Reader comments



Insulin Pumpers and Insulin Pumpers UK are supported financially by voluntary contributions from members of its discussion groups and from all the principal insulin pump manufacturers.

editor@insulin-pumpers.org.uk www.insulin-pumpers.org.uk/prosandcons/index.shtml ©1999-2013 Insulin Pumpers